Literature DB >> 9090485

Pathobiology of vulvar squamous neoplasia.

C P Crum1, C M McLachlin, J E Tate, G L Mutter.   

Abstract

Vulvar squamous carcinoma is an uncommon neoplasm that afflicts a spectrum of women and has been associated with granulomatous vulvar diseases, papillomaviruses, and chronic inflammatory disorders of the vulva. Histopathological, molecular, and epidemiological studies have revealed two subsets of vulvar squamous neoplasia, which are distinguished by their association with human papillomaviruses and patient demographics. This review summarizes the evidence both supporting the diverse pathogenesis of these tumors and the existence of factors that may be common to both groups. Ultimately, the pathway to both human papillomavirus positive and negative vulvar cancers may involve not only obvious precancerous changes but also biological events in the vulvar mucosa that precede the onset of morphological atypia.

Entities:  

Mesh:

Year:  1997        PMID: 9090485

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  15 in total

Review 1.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.

Authors:  Amy Baldwin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 3.  Human Papilloma Virus (HPV) in head and neck region: review of literature.

Authors:  L Mannarini; V Kratochvil; L Calabrese; L Gomes Silva; P Morbini; J Betka; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-06       Impact factor: 2.124

4.  Expression profiling of vulvar carcinoma: clues for deranged extracellular matrix remodeling and effects on multiple signaling pathways combined with discrete patient subsets.

Authors:  Kalliopi I Pappa; Jasmine Jacob-Hirsch; George D Vlachos; Ioanna Christodoulou; George Partsinevelos; Ninette Amariglio; Sofia Markaki; Aris Antsaklis; Nicholas P Anagnou
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

Review 5.  The role of human papillomavirus infection in breast cancer.

Authors:  Ting Wang; Peng Chang; Ling Wang; Qing Yao; Wen Guo; Jianghao Chen; Tristan Yan; Christopher Cao
Journal:  Med Oncol       Date:  2011-02-13       Impact factor: 3.064

6.  Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin.

Authors:  J A Carlson; K Healy; T A Tran; J Malfetano; V L Wilson; A Rohwedder; J S Ross
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7.

Authors:  Kwong Y Tsang; Massimo Fantini; Romaine I Fernando; Claudia Palena; Justin M David; James W Hodge; Elizabeth S Gabitzsch; Frank R Jones; Jeffrey Schlom
Journal:  Vaccine       Date:  2017-04-04       Impact factor: 3.641

8.  Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas.

Authors:  Sigrid Regauer; Olaf Reich; Christine Beham-Schmid
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 9.  HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

Authors:  Maura L Gillison; Anil K Chaturvedi; Douglas R Lowy
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

10.  High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.

Authors:  Nicholas A Wallace; Sujita Khanal; Kristin L Robinson; Sebastian O Wendel; Joshua J Messer; Denise A Galloway
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.